N. Vuilleumier

M. Burnier, M. Pruijm, S. Pagano, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-κB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis

F. Mach, F. Montecucco, D. Palombo, 2014, Mediators of inflammation.

Cardiac biomarkers for risk stratification in non‐massive pulmonary embolism: a multicenter prospective study

D. Hochstrasser, T. Perneger, N. Mensi, 2009, Journal of thrombosis and haemostasis : JTH.

Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism.

D. Hochstrasser, A. Rosset, Jean-Charles Sanchez, 2008, Thrombosis research.

Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis

F. Mach, S. Pagano, P. Fontana, 2016, Thrombosis and Haemostasis.

Receptor activator of NF-κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability

O. Ratib, F. Mach, S. Pagano, 2011, Thrombosis and Haemostasis.

Relationship between paraoxonase‐1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study

P. Fontana, J. Reny, N. Vuilleumier, 2011, Journal of thrombosis and haemostasis : JTH.

Plasmatic biomarkers of inflammation correlate with 18FDG-PET-CT and microembolic signals in patients with carotid stenosis

K. Lovblad, O. Ratib, N. Vuilleumier, 2018, Vessel Plus.

CRP-Based Cardiovascular Risk Assessment: New Conventional CRP Assay Fit for Purpose?

P. Lescuyer, N. Vuilleumier, M. Rossier, 2018, The journal of applied laboratory medicine.

Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population

Z. Kutalik, P. Marques‐Vidal, P. Vollenweider, 2017, Arteriosclerosis, thrombosis, and vascular biology.

CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes.

A. Maturana, S. Pagano, F. Montecucco, 2015, Endocrinology.

Anti‐ApoA‐1 IgGs predict resistance to waist circumference reduction after Mediterranean diet

P. Portincasa, S. Pagano, F. Montecucco, 2020, European journal of clinical investigation.

Changes of lipoprotein(a) levels with endogenous steroid hormones

M. Burnier, G. Ehret, F. Mach, 2021, European journal of clinical investigation.

Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case.

F. Mach, F. Montecucco, F. Carbone, 2014, World journal of clinical cases.

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?

S. Pagano, G. Foster, N. Vuilleumier, 2018, Hepatology International.

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease

J. Ärnlöv, J. Carrero, T. Fall, 2018, Journal of Nephrology.

Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes

A. von Eckardstein, L. Räber, N. Rodondi, 2019, Journal of clinical medicine.

Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis

D. Courvoisier, N. Vuilleumier, P. Lalive, 2015, Journal of Neuroimmunology.

Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation

F. Mach, E. Favari, B. Gencer, 2019, Journal of clinical medicine.

Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment

Z. Pataky, Aurélien Thomas, N. Vuilleumier, 2021, Physiological reports.

CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?

S. Pagano, N. Vuilleumier, P. Keller, 2012 .

Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort.

F. Mach, A. Calmy, B. Gencer, 2019, Atherosclerosis.

Kinetics of inflammatory biomarkers to predict one-year mortality in elderly patients hospitalized for pneumonia: a multivariable analysis.

Jean-Charles Sanchez, S. Pagano, D. Zekry, 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?

B. Ludewig, S. Pagano, N. Vuilleumier, 2021, European journal of clinical investigation.

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

P. Marques‐Vidal, P. Vollenweider, G. Waeber, 2020, Clinical & translational immunology.

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence

S. Yerly, S. Baggio, I. Guessous, 2022, European journal of clinical investigation.

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1

S. Yerly, I. Guessous, S. Stringhini, 2021, European journal of clinical investigation.

SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1

I. Guessous, S. Stringhini, J. Pugin, 2021, Atherosclerosis.

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

A. Flahault, A. Azman, J. Perez-Saez, 2021, The Lancet Infectious Diseases.

Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives

P. Cutler, N. Vuilleumier, P. C. Teixeira, 2012, Clinical & developmental immunology.

Emerging biomarkers for cardiac arrhythmias.

N. Vuilleumier, M. Namdar, A. Hammerer-Lercher, 2019, Clinical biochemistry.

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients

S. Bakker, S. Pagano, F. Kuipers, 2019, Journal of clinical medicine.

Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus

S. Pagano, N. Vuilleumier, R. Dullaart, 2019, International journal of molecular sciences.

Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.

N. Vuilleumier, N. Satta, 2015, Current drug targets.

Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice

J. Vallée, F. Mach, F. Montecucco, 2013, Thrombosis and Haemostasis.

Treatment with Evasin‐3 abrogates neutrophil‐mediated inflammation in mouse acute pancreatitis

F. Mach, F. Montecucco, F. Carbone, 2014, European journal of clinical investigation.

ELISA methods comparison for the detection of auto-antibodies against apolipoprotein A1.

S. Pagano, N. Vuilleumier, J. Batuca, 2019, Journal of immunological methods.

Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner

C. Weber, B. Cravatt, S. Steffens, 2019, Thrombosis and Haemostasis.

Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study

A. Azman, D. Pittet, I. Guessous, 2021, Occupational and Environmental Medicine.

Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland

P. Lescuyer, A. Azman, J. Perez-Saez, 2021, Nature Communications.

Impact of restricting procalcitonin measurements in a Swiss tertiary-care hospital on antibiotic use, clinical outcomes, and costs: An interrupted time-series analysis

M. Abbas, S. Harbarth, N. Vuilleumier, 2020, Infection Control & Hospital Epidemiology.

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA

A. Trkola, B. Ludewig, S. Pagano, 2022, RMD Open.

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses

B. Ludewig, S. Pagano, N. Vuilleumier, 2021, The Lancet Rheumatology.

Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution

I. Guessous, S. Joost, S. Stringhini, 2020, The Lancet Digital Health.

Infection-Induced Humoral Autoimmunity: A Missing Link in the Interplay Between Pathogens, Dyslipidemia, and Innate Immunity?

P. Vollenweider, S. Pagano, N. Vuilleumier, 2018, Journal of the American College of Cardiology.

Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.

F. Mach, A. Calmy, B. Gencer, 2017, The Journal of infection.

University of Groningen Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus Dullaart,

S. Pagano, N. Vuilleumier, R. Dullaart, 2019 .

Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters

A. Azman, I. Guessous, S. Joost, 2021, Frontiers in Public Health.

Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39‐R43 of β2‐glycoprotein I

F. Mach, F. Montecucco, D. Baptista, 2022, Research and practice in thrombosis and haemostasis.

Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.

S. Rudaz, F. Mach, R. Fraga-Silva, 2015, Vascular pharmacology.

A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples

S. Maerkl, B. Meyer, L. Kaiser, 2020, Proceedings of the National Academy of Sciences.

Household Transmission of SARS-COV-2: Insights from a Population-based Serological Survey

D. Cummings, A. Flahault, S. Lauer, 2020, medRxiv.

Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

A. Azman, J. Perez-Saez, S. Yerly, 2021, Clinical Microbiology and Infection.

Persistence and detection of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

A. Azman, J. Perez-Saez, S. Yerly, 2021, medRxiv.

Appendix: Seroprevalence of anti-SARS-COV-2 IgG antibodies in a population-based sample from Geneva, Switzerland

Dusan Petrovic, Antoine Flahault, Didier Pittet, 2020 .

Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings

S. Yerly, I. Guessous, S. Stringhini, 2021, Journal of clinical medicine.

Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

S. Yerly, S. Baggio, B. Meyer, 2021, Clinical Microbiology and Infection.

Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study

A. Flahault, N. Low, A. Azman, 2020, medRxiv.

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity

I. Hafström, N. Vuilleumier, J. Bratt, 2010, Scandinavian journal of rheumatology.

Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions.

E. Favari, N. Ronda, J. Nofer, 2015, Handbook of experimental pharmacology.

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.

N. Stergiopulos, A. Gayet-Ageron, F. Mach, 2012, European heart journal.

Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP

A. Lascano, P. Roux‐Lombard, N. Vuilleumier, 2021, Neurology: Neuroimmunology & Neuroinflammation.

High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.

S. Daskalopoulou, E. Favari, N. Vuilleumier, 2020, Metabolism: clinical and experimental.

Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia

Jean-Charles Sanchez, S. Pagano, D. Zekry, 2021, Journal of clinical medicine.

Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021

A. Azman, J. Perez-Saez, D. Pittet, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland

A. Azman, J. Perez-Saez, D. Pittet, 2021, medRxiv.

Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study

A. Azman, I. Guessous, S. Stringhini, 2021, medRxiv.

Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care

L. Lacroix, S. Stringhini, A. Gonçalves, 2020, Clinical Infectious Diseases.

Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care

L. Lacroix, S. Stringhini, A. Gonçalves, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests

S. Yerly, I. Guessous, S. Stringhini, 2020, Journal of clinical medicine.

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma

S. Yerly, S. Pagano, L. Kaiser, 2020, medRxiv.

Validation of a commercially available SARS-CoV-2 serological immunoassay

S. Yerly, I. Guessous, S. Stringhini, 2020, Clinical Microbiology and Infection.

Antibody Persistence in the Six Months Following SARS-CoV-2 Infection Among Hospital Workers

S. Yerly, B. Meyer, A. L'Huillier, 2020 .

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)

S. Yerly, G. Godeke, C. Reusken, 2020, Emerging microbes & infections.

Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

F. Mach, F. Montecucco, F. Carbone, 2015, European journal of clinical investigation.

Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America

S. Baggio, F. Negro, F. Chappuis, 2018, Journal of tropical medicine.

Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

F. Mach, F. Montecucco, F. Carbone, 2014, World journal of cardiology.

Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

F. Mach, F. Montecucco, F. Carbone, 2015, Antioxidants & redox signaling.

Pathophysiological role of neutrophils in acute myocardial infarction

F. Montecucco, F. Carbone, A. Nencioni, 2013, Thrombosis and Haemostasis.

Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation

D. Shah, H. Burri, F. Mach, 2018, The Journal of international medical research.

Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy

C. Combescure, F. Mach, S. Pagano, 2013, Thrombosis and Haemostasis.

DHEA prevents mineralo- and glucocorticoid receptor-induced chronotropic and hypertrophic actions in isolated rat cardiomyocytes.

A. Maturana, N. Vuilleumier, M. Rossier, 2013, Endocrinology.

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis

F. Mach, F. Montecucco, F. Carbone, 2016, Mediators of inflammation.

Gene regulation contributes to explain the impact of early life socioeconomic disadvantage on adult inflammatory levels in two cohort studies

O. Delaneau, T. Lehtimäki, Z. Kutalik, 2021, Scientific reports.

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis

D. Hochstrasser, P. Dayer, J. Desmeules, 2006, European Journal of Clinical Pharmacology.

Pharmacological Intervention to Modulate HDL: What Do We Target?

N. Vuilleumier, R. Schulz, S. Lecour, 2018, Front. Pharmacol..

Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury

F. Mach, Aurélien Thomas, F. Montecucco, 2015, PloS one.

Prognostic value of PCSK9 levels in patients with acute coronary syndromes.

L. Räber, R. Auer, N. Rodondi, 2016, European heart journal.

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

P. Cutler, F. Mach, F. Cerini, 2015, PloS one.

Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques

F. Mach, F. Montecucco, F. Carbone, 2020, International journal of molecular sciences.

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity.

F. Montecucco, O. Hartley, N. Vuilleumier, 2014, World journal of cardiology.

Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases

S. Pagano, F. Montecucco, P. Roux‐Lombard, 2013, Clinical Reviews in Allergy & Immunology.

Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT)

S. Yerly, G. Godeke, C. Reusken, 2020, medRxiv.

Automated Incubation and Digital Image Analysis of Chromogenic Media Using Copan WASPLab Enables Rapid Detection of Vancomycin-Resistant Enterococcus

J. Schrenzel, N. Vuilleumier, A. Cherkaoui, 2019, Front. Cell. Infect. Microbiol..

Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels.

F. Mach, A. Maturana, S. Pagano, 2012, Endocrinology.

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

B. Ludewig, N. Vuilleumier, J. von Kempis, 2021, The Lancet Rheumatology.

Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease.

J. Dayer, P. Roux‐Lombard, N. Vuilleumier, 2004, Journal of autoimmunity.

Humoral immunity against HDL particle: a new perspective in cardiovascular diseases?

S. Pagano, N. Vuilleumier, N. Satta, 2019, Current pharmaceutical design.

Diagnostic and prognostic value of autoantibodies anti‐apolipoprotein A‐1 and anti‐phosphorylcholine in acute non‐ST elevation myocardial infarction

S. Pagano, F. Montecucco, N. Vuilleumier, 2015, European journal of clinical investigation.

CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.

Fabrizio Montecucco, François Mach, Sébastien Lenglet, 2012, European heart journal.

GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation

W. Enard, S. Steffens, S. Pagano, 2021, bioRxiv.

Inferior vena cava parameters predict re‐admission in ischaemic heart failure

F. Mach, F. Viazzi, F. Montecucco, 2014, European journal of clinical investigation.

Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4

N. Stergiopulos, R. Fraga-Silva, C. Monaco, 2015, Thrombosis and Haemostasis.

Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms

Z. Kutalik, P. Vollenweider, G. Waeber, 2017, Front. Immunol..

Anti-Apolipoprotein A-1 IgG Levels Predict Coronary Artery Calcification in Obese but Otherwise Healthy Individuals

O. Ratib, F. Mach, S. Pagano, 2012, Mediators of inflammation.

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

F. Mach, R. Nkoulou, S. Pagano, 2010, European heart journal.

Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism

P. Lescuyer, D. Aujesky, N. Vuilleumier, 2016, PloS one.

Biomarkers for cardiovascular risk assessment in autoimmune diseases

P. Cutler, N. Vuilleumier, P. Ferber, 2015, Proteomics. Clinical applications.

Risk stratification of elderly patients with acute pulmonary embolism

B. Lämmle, M. Aschwanden, N. Rodondi, 2019, European journal of clinical investigation.

Prognostic value of total testosterone levels in patients with acute coronary syndromes.

L. Räber, R. Auer, N. Rodondi, 2019, European journal of preventive cardiology.

Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non‐high‐risk pulmonary embolism

P. Lescuyer, D. Aujesky, N. Vuilleumier, 2015, Journal of internal medicine.

Prognostic value of PCSK 9 levels in patients with acute coronary syndromes

L. Räber, R. Auer, N. Rodondi, 2016 .

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis

S. Pagano, N. Vuilleumier, C. Juillard, 2020, Oncotarget.

Association of novel biomarkers with major clinical outcomes in a cohort of patients with atherosclerotic renovascular disease

S. Pagano, P. Kalra, N. Vuilleumier, 2019, Annals of clinical biochemistry.

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.

D. Hochstrasser, C. Lovis, F. Mach, 2010, Arthritis and rheumatism.

Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis

F. Mach, F. Montecucco, F. Carbone, 2013, Thrombosis and Haemostasis.

Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population

F. Bastardot, P. Vollenweider, G. Waeber, 2016, Thrombosis and Haemostasis.

Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice

A. Ballestrero, F. Patrone, N. Stergiopulos, 2013, Thrombosis and Haemostasis.

Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population

F. Mach, B. Gencer, D. Courvoisier, 2015, European journal of clinical investigation.

Diagnostic accuracy of Augurix COVID‐19 IgG serology rapid test

S. Yerly, I. Guessous, S. Stringhini, 2020, European journal of clinical investigation.

Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.

F. Mach, S. Pagano, F. Montecucco, 2011, European heart journal.

A9.11 Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: a role in atherothrombosis

F. Mach, S. Pagano, F. Montecucco, 2014 .

Clinical method evaluation of hemoglobin S and C identification by top-down selected reaction monitoring and electron transfer dissociation

P. Lescuyer, D. Hochstrasser, Alexander Scherl, 2019, Clinical Proteomics.

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

D. Hochstrasser, D. Courvoisier, S. Pagano, 2012, Arthritis care & research.

Performance of Fully Automated Antimicrobial Disk Diffusion Susceptibility Testing Using Copan WASP Colibri Coupled to the Radian In-Line Carousel and Expert System

J. Schrenzel, N. Vuilleumier, A. Cherkaoui, 2021, Journal of clinical microbiology.

Impact of Total Laboratory Automation on Turnaround Times for Urine Cultures and Screening Specimens for MRSA, ESBL, and VRE Carriage: Retrospective Comparison With Manual Workflow

J. Schrenzel, S. Harbarth, N. Vuilleumier, 2020, Frontiers in Cellular and Infection Microbiology.

Implementation of the WASPLab™ and first year achievements within a university hospital

J. Schrenzel, N. Vuilleumier, A. Cherkaoui, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Rapid identification by MALDI-TOF/MS and antimicrobial disk diffusion susceptibility testing for positive blood cultures after a short incubation on the WASPLab

J. Schrenzel, N. Vuilleumier, A. Cherkaoui, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Comparison of the Copan WASPLab incorporating the BioRad expert system against the SIRscan 2000 automatic for routine antimicrobial disk diffusion susceptibility testing.

Jacques Schrenzel, Gesuele Renzi, J. Schrenzel, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Copan WASPLab automation significantly reduces incubation times and allows earlier culture readings.

J. Schrenzel, N. Vuilleumier, A. Cherkaoui, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice.

N. Stergiopulos, F. Mach, R. Fraga-Silva, 2015, Vascular pharmacology.

Impact of long distance rowing on biological health: A pilot study.

F. Mach, B. Gencer, N. Vuilleumier, 2017, Clinical biochemistry.

Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study

T. Perneger, O. Rutschmann, B. Ponte, 2017, BMC Nephrology.

Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages.

P. Lescuyer, F. Mach, S. Pagano, 2016, Vascular pharmacology.

18FDG-PET-CT: An Imaging Biomarker of High-Risk Carotid Plaques. Correlation to Symptoms and Microembolic Signals

K. Lovblad, O. Ratib, S. Pagano, 2014, Stroke.

Profound hyponatraemia in the emergency department: seasonality and risk factors.

O. Rutschmann, T. Huwyler, N. Vuilleumier, 2016, Swiss medical weekly.

Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases

S. Pagano, C. Gabay, N. Vuilleumier, 2023, Frontiers in Immunology.

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.

F. Mach, F. Montecucco, F. Carbone, 2015, Vascular pharmacology.

Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects

F. Mach, E. Favari, Eleonora Cipollari, 2019, Journal of clinical medicine.

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease

S. Pagano, N. Vuilleumier, R. Dullaart, 2023, Biomolecules.

Update on the efficacy of statin treatment in acute coronary syndromes

F. Mach, F. Montecucco, F. Carbone, 2014, European journal of clinical investigation.

Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients

I. Guessous, S. Stringhini, J. Pugin, 2023, Nutrients.

Head-to-Head Comparison of Auto-Antibodies for Cardiovascular Outcome Prediction after Myocardial Infarction: a Prospective Study

F. Mach, S. Pagano, E. Charbonney, 2011 .

Serum OPN levels are up regulated and predict disability after an ischemic stroke

F. Montecucco, F. Carbone, F. Dallegri, 2021 .

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations

F. Mach, F. Montecucco, N. Vuilleumier, 2012, Mediators of inflammation.

Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels.

F. Mach, A. Maturana, S. Pagano, 2012, Endocrinology.

CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.

B. Delattre, J. Vallée, F. Mach, 2012, European heart journal.

Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis

D. Courvoisier, N. Vuilleumier, P. Lalive, 2015, Journal of Neuroimmunology.

1 Impact of CD 14 polymorphisms on anti-apolipoprotein A-1 IgG-related coronary artery 1 disease prediction in the general population 2 3

Z. Kutalik, G. Waeber, F. Mach, 2017 .

Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.

F. Mach, S. Pagano, F. Montecucco, 2011, European heart journal.

The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.

M. Pruijm, S. Pagano, P. Kalra, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Anti‐apolipoprotein A‐1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex

S. Pagano, N. Vuilleumier, N. Satta, 2012, Journal of internal medicine.

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.

D. Hochstrasser, C. Lovis, F. Mach, 2010, Arthritis and rheumatism.

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study

S. Pagano, N. Vuilleumier, R. Dullaart, 2023, Journal of Translational Medicine.

Antiapolipoprotein A-1 Autoantibody Positivity Is Associated with Threatened Abortion

S. Pagano, F. Montecucco, F. Carbone, 2020, BioMed research international.

Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus

S. Pagano, N. Vuilleumier, R. Dullaart, 2019, International journal of molecular sciences.

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?

S. Pagano, G. Foster, N. Vuilleumier, 2018, Hepatology International.

Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.

F. Mach, A. Calmy, B. Gencer, 2017, The Journal of infection.

Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population

F. Bastardot, P. Vollenweider, G. Waeber, 2016, Thrombosis and Haemostasis.

Anti‐ApoA‐1 IgG serum levels predict worse poststroke outcomes

F. Mach, F. Montecucco, F. Carbone, 2016, European journal of clinical investigation.

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?

A. von Eckardstein, J. Dayer, P. Roux‐Lombard, 2013, Swiss medical weekly.

Title : Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population . Results from the CoLaus study

F. Bastardot, P. Vollenweider, G. Waeber, 2022 .

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

F. Mach, R. Nkoulou, S. Pagano, 2010, European heart journal.

Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD)

M. Taal, D. Wheeler, P. Roderick, 2023, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.